The company that makes the world’s biggest-selling gene test for breast and ovarian cancers is refusing to share groundbreaking knowledge that could benefit patients, academics claim. Myriad Genetics is accused of deliberately withholding data that could help other scientists to understand cancer genetics, on the grounds that the information is commercially sensitive.
View the original article here: Genetic Profiteering: Scandal of firm ‘hiding vital breast cancer data’
 |
Infographics | More... |
Viewpoint: The organic food industry is a $180 billion marketing fraud 
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
How Wegovy and Ozempic could transform our food systems 
Frankenfoods? A ‘terrible word’ that could describe more foods than you might realize 
The increasingly bushy human family tree and five other paradigm-altering changes in our understanding of human evolution 
Blue soybeans? Orange wheat? How a gene-edited splash of color could make robotic weeding much easier 
Viewpoint: Will India embrace a second green revolution — one focused on sustainable agriculture instead of yield? 
Out of Africa revisited: Where did humans migrate after leaving the continent? 
Does GMO corn increase crop yields? More than 20 years of data confirm it does — and provides substantial health and safety benefits 
How Freddie Mercury got his voice: It wasn’t his teeth 
